HomeHealthcarePharmaceuticals Hyperpigmentation Treatment Market

Hyperpigmentation Treatment Market Size, Share & Trends Analysis Report By Treatment Type (Topical Treatments (Creams and Serums), Procedural Treatments), By Application (Age Spots, Melasma, Post-inflammatory Hyperpigmentation (PIH), Freckles, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Debashree Bora | Format:

Hyperpigmentation Treatment Market Size & Growth Analysis

The global hyperpigmentation treatment market size was valued at USD 1.46 billion in 2025 and is projected to grow from USD 1.55 billion in 2026 to USD 2.56 billion by 2034, registering a CAGR of 6.45% during the forecast period from 2026 to 2034. North America dominated the hyperpigmentation treatment market with a market share of 52.86% in 2025.

The global hyperpigmentation treatment market encompasses a diverse range of therapeutic solutions aimed at reducing excess melanin production and restoring even skin tone, playing a vital role in dermatological care and aesthetic medicine. By treatment type, the market is segmented into topical and procedural treatments. Topical treatments include hydroquinone-based creams, retinoids, vitamin C serums, and kojic acid creams, which are primarily used for mild to moderate pigmentation. Procedural treatments consist of laser and light-based therapies such as Q-switched lasers, fractional lasers, and intense pulsed light (IPL), as well as chemical peels including glycolic acid, salicylic acid, and TCA peels, alongside microneedling and platelet-rich plasma (PRP) therapies that enhance collagen production and skin renewal. By application, the market is categorized into age spots, melasma, post-inflammatory hyperpigmentation (PIH), freckles, and others, with melasma and PIH accounting for a share due to their prevalence and recurrence. Continuous advancements in combination therapies, customized formulations, and device-based procedures, along with the growing adoption of AI-driven skin analysis and rising consumer awareness of aesthetic dermatology, are propelling the global market toward steady growth.

Market Key Takeaways

Global Market Size & Growth

North America held a dominant share of the global market, accounting for 52.86% share in 2025.
The Asia Pacific region is growing at the fastest pace, with a CAGR of 8.26%.
Treatment Type
The topical treatments (creams and Serums) segment is expected to register the fastest CAGR growth of 7.31%.
Application
The age spots segment held the highest market share of 37.11% in 2025.
The U.S. dominates the global market, valued at USD 676.80 million in 2024 and reaching USD 717.50 million in 2025.
2025 Market Size
USD 1.46 billion
2034 Projected Market Size
USD 2.55 billion
CAGR (2025 to 2034)
6.45%
Dominating Region
North America
Fastest-Growing Region
Asia Pacific
Hyperpigmentation Treatment Market Size , Share and Growth Forecast 2026-2034

Download a Free SampleTo learn more about this report.

Treatment Type Insights

The topical treatments (Creams and Serums) segment is anticipated to grow at a CAGR of 7.31% during 2026 - 2034. The growth is attributed to the increasing preference of consumers for the non-invasive treatments, easy to use skincare solutions that target hyperpigmentation and uneven skin tone, coupled with the rising awareness about dermatologically tested products as well as availability of advanced formulations enriched with actives, such as tranexamic acid, niacinamide and vitamin c.

The procedural treatments dominated the market in 2025, due to the growing preference for targeted pigment removal technologies that enable precise melanin disruption at cellular levels, minimizing recurrence and improving skin tone uniformity in resistant pigmentation conditions such as melasma and post-inflammatory hyperpigmentation.

Hyperpigmentation Treatment Market Size By Segments

Request Customizationto receive a tailored report.

Application Insights

The age spots segment dominated the market with a revenue share of 37.11% in 2025. This growth is attributed to the increasing consumer awareness about skin aging, rising adoption of preventive skincare routines and availability of advanced formulations targeting age spots, which further enhance the market growth.

The post-inflammatory hyperpigmentation (PIH) segment is anticipated to register the fastest CAGR of 7.56% during the forecast period, driven by the rising prevalence of acne, eczema, and cosmetic procedures that often lead to pigmentation irregularities.

Hyperpigmentation Treatment Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Analysis

The North America region dominated the market with a revenue share of 52.86% in 2025. The growth is attributed to factors such as the presence of well-established dermatology clinics as well as cosmetic centers.

The hyperpigmentation treatment market in the U.S. is widely driven by the support of the government towards clinical research on skin health for improving healthcare outcomes, which also enhances the market growth. As per the U.S. FDA, several new treatments were approved, including the advanced topical creams as well as laser therapies that further expand the market growth.

North America Hyperpigmentation Treatment Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Market Insights

The Asia Pacific region is the fastest-growing region with a CAGR of 8.26% during the forecast timeframe. The growth is attributed to factors such as a large and growing population. In addition, several brands and products in the region are focusing on dermatological health via public awareness campaigns, which further boosts the demand for hyperpigmentation treatments.

The rising popularity of personalized skincare solutions targeting skin brightening and pigmentation correction, fueled by increasing consumer demand for tailored dermatological treatments, enhances the market growth. Chinese consumers are increasingly adopting AI-powered skin analysis apps offered by brands like Perfect Diary, which recommend customized serums and treatment routines to specifically address melasma, age spots, and post-inflammatory hyperpigmentation.

Europe Market Insights

The hyperpigmentation treatment market in Europe is propelling due to technological advancements in the treatment options, such as laser therapies, as well as topical agents, which have further contributed to market expansion.

The rising demand for natural and clinically tested topical formulations that cater to sensitive skin while effectively reducing pigmentation drives the market growth. For example, brands such as Babor offer scientifically validated serums and creams containing ingredients such as niacinamide and vitamin C, which are gaining popularity among German consumers who prefer safe, dermatologist-recommended skincare solutions.

Middle East and Africa Market Insights

A driver for the Middle East and Africa hyperpigmentation market is the growing emphasis on sun protection and skin brightening solutions, driven by high UV exposure and cultural preferences for uniform skin tone. For example, consumers in countries like the United Arab Emirates and Saudi Arabia are increasingly using combination therapies that include SPF-enriched brightening creams and laser treatments to prevent and manage age spots and post-inflammatory hyperpigmentation.

The increasing demand for dermatologically approved treatments targeting post-inflammatory hyperpigmentation caused by acne and skin injuries, driven by a growing awareness of skin health and cosmetic appearance, enhances the market growth. South African consumers are increasingly turning to clinically tested serums with ingredients like kojic acid and vitamin C, as well as in clinic procedures such as chemical peels, to effectively reduce dark spots and achieve an even skin tone.

Latin America Market Insights

The expanding availability of affordable dermatology clinics and aesthetic centers in urban areas, which makes professional treatments more accessible to a wider population, enhances the market growth. For example, in Brazil and Argentina, the growth of local clinics offering microneedling, chemical peels, and laser-based pigmentation correction has enabled more consumers to seek effective solutions for age spots, melasma, and post-inflammatory hyperpigmentation.

The increasing demand for natural and plant-based skincare formulations that cater to consumers seeking safe and gentle alternatives for pigmentation management enhances the market growth. The brands are developing serums and creams containing botanical extracts like licorice root, aloe vera, and chamomile, which are gaining popularity among consumers aiming to treat melasma and dark spots without harsh chemicals.

Competitive Landscape

The global hyperpigmentation treatment sector is highly fragmented in nature due to the diverse range of multinational companies and emerging dermatological brands. The top players are L'Oréal S.A., Unilever, Beiersdorf AG, Candela Corporation, and others.

M. Collin: An emerging market player

G.M. Collin offers products with an aim of providing advanced product formulation as a dermo-corrective skin care solution.

  • In June 2025, G.M. Collin launched a dark spot serum, which is designed to target hyperpigmentation, including dark spots as well as signs of aging.

List of Key and Emerging Players in Hyperpigmentation Treatment Market

L'Oréal S.A.
Unilever
Beiersdorf AG
Candela Corporation
Obagi Cosmeceuticals LLC
SkinCeuticals
La Roche-Posay
Vivier Pharma Canada
iS Clinical
BIODERMA
CP Skin Health Group, Inc.
ISDIN
Shiseido Co., Ltd.
Uriage
Episciences, Inc.
Johnson and Johnson Innovation LLC
Procter and Gamble, Plz
Menarini Asia-Pacific Pte. Ltd.
Topicals
Image Skincare
Others

Key Industry Developments

March 2026
L’Oréal expanded its dermatological skincare portfolio with new pigment-correction solutions under its skincare brands, incorporating advanced formulations targeting uneven skin tone and hyperpigmentation concerns.
September 2025
Galderma introduced new aesthetic dermatology products and treatment solutions focused on skin rejuvenation, pigmentation management, and advanced skincare applications.
May 2025
Beiersdorf expanded its skincare innovation portfolio with new Eucerin products designed to address hyperpigmentation and improve skin tone through science-based dermatological formulations.

Report Scope

Segmentation

By Treatment Type 2
  • Topical Treatments (Creams and Serums)
  • Procedural Treatments
By Application 5
  • Age Spots
  • Melasma
  • Post-inflammatory Hyperpigmentation (PIH)
  • Freckles
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • South East Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage L'Oréal S.A. · Unilever · Beiersdorf AG · Candela Corporation · Obagi Cosmeceuticals LLC
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Reportto Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The hyperpigmentation treatment market size is valued at USD 1.55 Billion in 2026 and is projected to reach USD 2.56 Billion by 2034, at a CAGR of 6.45% during the forecast period 2026-2034.
North America dominated the market with a share of 52.86% in 2025.
The leading players in this market are L'Oreal S.A., Unilever, Beiersdorf AG, Candela Corporation, Obagi Cosmeceuticals LLC.
The hyperpigmentation treatment market is projected to grow at a CAGR of 6.45% during the forecast period of 2026 2034.
About the Author
Debashree Bora
Debashree Bora
Healthcare Lead

Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, and competitive dynamics.
Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.

Report Details
−
Trusted by Industry Leaders
LG ElectronicsAMCAD EngineeringKOBE STEEL LTD.Hindustan National Glass & Industries LimitedVoith GroupInternational PaperHansol PaperWhirlpool CorporationSonySamsung ElectronicsQualcommGoogleFiservVeto-PharmaNippon Becton DickinsonMerckArgon Medical DevicesAbbottAjinomotoDenonDoosanMeiji Seika Kaisha LtdLG ChemicalsLCY chemical groupBayerAirraneBASFToyota IndustriesNissan MotorsNeenahMitsubishiHyundai Motor CompanyHondaCRP Industries IncpewagLGEPanasonicLubrizol CorporationLeonardoJohnson & JohnsonHB FullerMITSUBISHI CHEMICALHyundai MobisAmazon
Request SampleOrder Report Now